Publication Name	World Journal of Gastroenterology
Manuscript ID	11029
Country	China

Received	2014-05-01 09:23
Peer-Review Started	2014-05-02 11:38
To Make the First Decision	2014-05-29 19:01
Return for Revision	2014-06-12 12:21
Revised	2014-07-05 00:00
Second Decision	2014-09-16 13:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-09-16 13:47
Articles in Press	2014-09-16 13:57
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-09-30 07:15
Typeset the Manuscript	2014-12-04 17:38
Publish the Manuscript Online	2014-12-18 17:08

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Jia-Yan Ni, Hong-Liang Sun, Yao-Ting Chen, Jiang-Hong Luo, Dong Chen, Xiong-Ying Jiang and Lin-Feng Xu
Funding Agency and Grant Number
Corresponding Author	Lin-Feng Xu, MD, PhD, Chief, Department of Interventional Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang Road West, Guangzhou 510120, Guangdong Province, China. xu_lin_feng@163.com
Key Words	Hepatocellular carcinoma; Transarterial chemoembolization; Microwave ablation; Survival; Prognosis
Core Tip	Transarterial chemoembolization (TACE) combined with microwave ablation (MWA) has been used more and more widely for treatment of patients with hepatocellular carcinoma (HCC). However, there has been no study designed to analyze prognostic factors for survival after TACE combined with MWA for HCC. In this study, we retrospectively collected clinicopathologic data of 86 patients who were treated by TACE sequentially combined with MWA, and to analyze prognostic factors for survival after the combinational therapy. We hope that our finding could serve as significant information for clinicians and patients in the decision for selecting treatment strategies.
Publish Date	2014-12-18 17:08
Citation	Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. World J Gastroenterol 2014; 20(46): 17483-17490
URL	http://www.wjgnet.com/1007-9327/full/v20/i46/17483.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i46.17483

Full Article (PDF)	WJG-20-17483.pdf
Full Article (Word)	WJG-20-17483.doc
Manuscript File	11029-Review.doc
Answering Reviewers	11029-Answering reviewers.pdf
Copyright License Agreement	11029-Copyright assignment.pdf
Peer-review Report	11029-Peer reviews.pdf
Scientific Misconduct Check	11029-CrossCheck.jpg
Scientific Editor Work List	11029-Scientific editor work list.pdf